ReviewFrontiers in medicine2022
Blood Group Testing.
Review in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- A global survey of blood transfusion practices for patients with sickle cell disease.Transfusion · 2026Article
- Dosing of anti-infective drugs in patients undergoing therapeutic plasma exchange - considerations for practical application: a narrative review.Critical care (London, England) · 2026Review
- Improving In Vitro Antibody Production Using Synthetic Peptide Derived from RhD Loops.Applied biochemistry and biotechnology · 2026Article
- Molecular Testing in Sickle Cell Disease: From Newborn Screening to Transfusion Care.International journal of laboratory hematology · 2026Review
- Quantitative holographic agglutination assay for immunoglobulin A.Biomedical optics express · 2026Article
- Hough's Transform-Based IoT Device for Automated Identification and Prediction of Blood Groups.Journal of biomedical physics & engineering · 2026Article
- [Rh blood group: Review and importance of genotyping].Revista medica del Instituto Mexicano del Seguro Social · 2026Review
- Use of Microbial Microarrays to Define Antibody Specificity.Methods in molecular biology (Clifton, N.J.) · 2026Article
- Bridging the Gap: High-ResolutionHuman mutation · 2026Article
- Impact of ABO Blood Group on Bleeding and Clotting Time Among Healthy North Indian Males: A Pilot Study.Cureus · 2025Article
- MATERNAL HEALTH LITERACY AND QUALITY OF CARE OFFERED TO PREGNANT WOMEN ATTENDING ANTENATAL CARE SERVICES IN LAGOS, NIGERIA.Annals of Ibadan postgraduate medicine · 2025Article
- Evaluation of Canine Erythrocyte Surface Antigens and Morphological Alterations Induced by Trypsin Treatment.Animals : an open access journal from MDPI · 2025Article
- The Discovery of New Antibody in Autoimmune Disease Using a Novel Approach of Coombs Test Based on Flow Cytometry Method.Journal of clinical laboratory analysis · 2025Article
- Multiplex-PCR technique to predict polymorphic antigens - M, N, S and s - and associations between their alleles and MiScientific reports · 2025Article
- Molecular advances in transfusion medicine: a narrative review.Frontiers in medicine · 2025Review
- Resolving Incompatible Blood Cross-Matching: The Role of 37°C Water Bath in Transfusion Safety.Journal of blood medicine · 2025Article
- Reliability of the documented blood group in motor vehicle driving license in Kerala, India - A public health concern?Journal of family medicine and primary care · 2024Article
- Red blood cell alloimmunization in blood transfusion-dependent β thalassemia major patients in Sana'a City-Yemen.Scientific reports · 2024Article
- The association between blood groups, Rhesus factors, body mass index and obesity among pregnant women at Gadarif Maternity Hospital, Eastern Sudan.BMC pregnancy and childbirth · 2023Article
- Establishment and application of suspension static method in blood group screening of automated blood group analyzer.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Red blood cell (RBC) transfusion is one of the most frequently performed clinical procedures and therapies to improve tissue oxygen delivery in hospitalized patients worldwide. Generally, the cross-match is the mandatory test in place to meet the clinical needs of RBC transfusion by examining donor-recipient compatibility with antigens and antibodies of blood groups. Blood groups are usually an individual's combination of antigens on the surface of RBCs, typically of the ABO blood group system and the RH blood group system. Accurate and reliable blood group typing is critical before blood transfusion. Serological testing is the routine method for blood group typing based on hemagglutination reactions with RBC antigens against specific antibodies. Nevertheless, emerging technologies for blood group testing may be alternative and supplemental approaches when serological methods cannot determine blood groups. Moreover, some new technologies, such as the evolving applications of blood group genotyping, can precisely identify variant antigens for clinical significance. Therefore, this review mainly presents a clinical overview and perspective of emerging technologies in blood group testing based on the literature. Collectively, this may highlight the most promising strategies and promote blood group typing development to ensure blood transfusion safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.